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Abstract
Introduction and hypothesis The objective of this study is
to evaluate the complications and anatomical and func-
tional outcomes of the surgical treatment of mesh-related
complications.
Methods A retrospective cohort study of patients who
underwent complete or partial mesh excision to treat
complications after prior mesh-augmented pelvic floor
reconstructive surgery was conducted.
Results Seventy-three patients underwent 30 complete and
51 partial mesh excisions. Intraoperative complications
occurred in 4 cases, postoperative complications in 13.
Symptom relief was achieved in 92% of patients. Recur-
rence of pelvic organ prolapse (POP) occurred in 29% of
complete and 5% of partial excisions of mesh used in POP
surgery. De novo stress urinary incontinence (SUI) occurred
in 36% of patients who underwent excision of a suburethral
sling.
Conclusions Mesh excision relieves mesh-related compli-
cations effectively, although with a substantial risk of
serious complications and recurrence of POP or SUI. More
complex excisions should be performed in skilled centers.
Keywords Complications.Excision.Exposure.Mesh.
Pelvic organ prolapse.Stress urinary incontinence
Abbreviations
IVS Intravaginal sling
OAB Overactive bladder
POP Pelvic organ prolapse
SUI Stress urinary incontinence
TOT Transobturator tape
TVT Tension-free vaginal tape
TVT-O Tension-free vaginal tape obturator
Introduction
Pelvic organ prolapse (POP) with or without stress urinary
incontinence (SUI) is a major health issue in older women.
The prevalence of POP-Q stage 2 or more varies from 37%
to 50% [1, 2]. A woman’s lifetime risk of undergoing
surgery for POP or SUI is approximately 11% [3]. Of those
who undergo vaginal prolapse repair of the anterior vaginal
wall, POP recurrence rates can reach 70% [4]. Given this
high recurrence rate after traditional vaginal prolapse
surgery, many pelvic reconstructive surgeons began to use
vaginal mesh to maintain the advantage of vaginal surgery
and to obtain improved support. The use of synthetic mesh
in procedures such as groin hernia surgery, abdominal
sacrocolpopexy, and suburethral slings has been proven to
be effective and is well established [5–7]. However, current
data suggest that the use of mesh in vaginal prolapse
surgery is associated with both benefits and risks. Few
randomized controlled trials have been published. They
reveal improved anatomic outcomes and lower recurrence
rates, but similar subjective outcomes and substantial mesh-
related complications after vaginal mesh placement when
compared to traditional vaginal prolapse repairs [8–11].
Mesh-related complications include mainly mesh expo-
sure [12] into the vagina or even the bladder or bowel,
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voiding problems. Pelvic abscesses and rectovaginal or
vesicovaginal fistula are also reported [13–17]. These
complications occur in approximately 10% of patients and
may lead to a significant decrease in quality of life [8–11,
18–20]. The extent of impact of mesh-related complications
on quality of life has so far not been investigated
thoroughly. Complications can be treated noninvasively in
selected cases. However, with more severe mesh-related
complications, partial or complete mesh excision is most of
the time unavoidable. A recent review reported a higher rate
of repeat surgery due to complications after vaginal mesh
procedure compared to the rate of repeat surgery due to
recurrent prolapse after conventional vaginal prolapse
surgery [21].
The objective of this retrospective cohort study is to
evaluate the surgical treatment of mesh-related complica-
tions with regard to complications and anatomical and
functional outcomes.
Materials and methods
We conducted a retrospective cohort study including all
patients who underwent surgical mesh excision, after prior
POP and/or SUI surgery with mesh, between January 2005
and September 2010 in the Department of Obstetrics and
Gynaecology of the Radboud University Nijmegen Medical
Centre, a tertiary referral center in the Netherlands. In
accordance with Dutch law, retrospective observational
studies are exempt from submission for approval to a
medical ethics review committee. Patients with mesh-
related complications that were effectively managed on an
outpatient basis were not included. Since we regarded
voiding dysfunction after insertion of a suburethral sling a
complication more specific for stress incontinence surgery
than for vaginal mesh in general, we excluded these
patients from further analysis (Fig. 1).
Patient characteristics, characteristics of mesh insertion
procedure, relevant surgical history, POP-Q stage [22], SUI
and overactive bladder (OAB) complaints before mesh
excision, symptoms and signs of mesh-related complica-
tions, and prior therapy were extracted from paper and
electronic medical records. Operative reports and hospital
discharge reports were used to collect characteristics of
mesh excision, additional surgery, intraoperative complica-
tions, postoperative complications, and hospital stay. Out-
comes after mesh excision including relief of mesh-related
symptoms, mesh exposure, recurrence of POP, de novo SUI
and OAB, and need of re-excision were collected at the
latest available moment of follow-up. The extent of
symptom relief was determined by patient history and
categorized into complete relief when patients expressed no
remaining symptoms, improvement when some symptoms
persisted, and no improvement when symptoms had been
unchanged. We defined recurrence of POP as the develop-
ment of at least POP stage 2 after mesh excision or increase
of POP with at least one stage when there was POP stage 2
before in the compartment where mesh was excised or
occurring after apical mesh excision.
Patients who underwent partial mesh excision, including
section of mesh, were compared to patients who underwent
complete mesh excision. Continuous variables were com-
pared using the Mann–Whitney U test. Categorical varia-
bles were compared using the chi-square test and, in case of
small numbers, with Fisher’s exact test. A P value of ≤0.05
Patients who underwent 
mesh excision 
N = 83 
Excluded: patients who had urinary 
retention after suburethral sling 
N = 10 
Patients who underwent 
mesh excision 
N = 73 
Patients who underwent 
mesh excision 
N = 75 
Patients who underwent 
second excision of other mesh 
N = 2 
Patients who underwent re-excision 
N = 6 
Procedures of 
mesh excision 
N = 81 
Complete excisions 
N = 30 
Partial excisions 
N = 49 
Sections 
N = 2 
Fig. 1 Flowchart of inclusion
of patients who underwent
excision of mesh
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using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).
Surgical technique
An examination under anesthesia was performed and the
problematic area of the mesh was identified. When there
was suspicion of mesh exposure in the bladder or bowel,
cystoscopy and/or rectal examination was used to identify
the presence of exposed mesh in the bladder or rectum.
Partial vaginal mesh excision
In case of a limited vaginal exposure with mild symptoms,
the exposure site was circumcised and the edges of the
vaginal epithelium were mobilized approximately 1 cm
around the exposure. The extruded part of the mesh was
then removed and the edges of the vaginal epithelium
trimmed, where appropriate, and reapproximated.
Complete mesh excision via the vaginal approach
When there were larger exposures, severe symptoms, and/
or involvement of the bladder or bowel (described in the
“Results” section), the intention was to perform total mesh
excision or to remove as much mesh as possible in case of
mesh arms passing through the obturator space, ischiorectal
fossa, or sacrum. The vaginal epithelium covering the mesh
was injected with normal saline or 0.5% lidocaine with
1:200,000 epinephrine for hydrodissection. A midline or
inverted U-shaped full-thickness incision was performed
over the palpable mesh and vaginal epithelium was sharply
dissected from the mesh as far laterally as possible. The
mesh, where necessary with a layer of interlaced fibrotic
tissue, was carefully dissected from the bladder or rectum
using both sharp and gentle blunt dissection. Sharp
dissection of posterior mesh was performed over a finger
placed into the rectum to avoid rectal injury. Once the body
of the mesh was freed and the mesh arms were visualized,
tension was applied to expose the maximum amount of
mesh. The body of the mesh was then separated from the
mesh arms at the most lateral position possible. In some
cases of excision of sacrocolpopexy mesh, a hysteroscope
was used to enable a higher and thus more complete mesh
removal. When hemostasis was achieved, the vaginal
epithelium was reapproximated. If necessary, concomitant
procedures for prolapse repair or other gynecologic dis-
orders were performed.
When the tape was also exposed intravesically, firstly,
two ureteral stents were inserted. The bladder was opened
through the pubocervical fascia and the tape excised, taking
utmost care of the ureters. The bladder was then closed in
two layers, taking care to avoid the ureters. The ureteral
stents were removed at the end of the procedure. The
bladder was drained for 7–14 days with an indwelling
catheter. An ultrasound control of the kidneys was
performed after 1 day.
Abdominal mesh excision
An abdominal approach was applied for the excision of
mesh used in sacrocolpopexy or suburethral slings when
previous vaginal approach has not been successful or in
case of extensive bladder involvement.
In abdominal excision of sacrocolpopexy mesh, the
abdominal cavity was accessed through a vertical midline
incision. The intestines were packed out of the pelvis with
moist laparotomy gauzes and held in place with a retractor.
Adhesiolysis was performed as necessary to allow adequate
visualization. The mesh was removed from the sacrum and
apex of the vagina by both sharp and blunt dissection. The
vaginal vault was closed, leaving a small opening for
postoperative drainage. For abdominal excision of trans-
vaginal tape (TVT) or excision of other intravesical
localized mesh, a Pfannenstiel incision allowed entry to
the Retzius space. After localizing the tape, it was dissected
from the abdominal wall and bladder.
In case of an intravesical exposure, dissection was
continued down to the point of entry of the tape into the
bladder, the bladder was opened, and the mesh was removed
completely. The bladder was then closed in two layers, taking
care to avoid the ureters. If necessary, any remaining mesh in
the vagina was removed by a vaginal approach as described
above. The bladder was drained for 7–14 days with an
indwelling catheter. When the resection had to be done in
proximity of the ureters, an ultrasound control of the kidneys
was performed after the meshexcisionprocedure and after the
removal of the ureteral stents.
Results
Between January 2005 and September 2010, 83 patients
underwent surgical excision of mesh used in POP or SUI
surgery. Ten patients required excision of mesh because of
urinary retention after insertion of a suburethral sling and
were withdrawn from further analysis. Of the remaining 73
patients who underwent mesh excision, 2 patients under-
went a second excision for other mesh in another
compartment. In further analysis, these 2 patients were
considered as 4 individuals, resulting in 75 patients. Six
patients required a re-excision of the same mesh. Overall,
there were 81 operations for mesh excision, of which 30
(37%) were complete excisions, 49 (61%) partial excisions,
and 2 (2%) sections of mesh (Fig. 1). In further analysis,
sections of mesh were considered as partial mesh excisions.
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excision are summarized in Table 1. A variety of mesh
materials were excised in our population: Gynemesh™,
Mersilene™, Prolift™, Ultrapro™,T V T ™,T V T - O ™
(Ethicon, Somerville, NJ, USA), IVS™ (Tyco Healthcare
L P ,N o r w a l k ,C T ,U S A ) ,A v a u l t a ™(CR Bard, Covington, GA,
USA), Apogee™ (American Medical Systems, Minnetonka,
MN, USA), EndoFast Reliant™ (Endogun Medical Systems,
Kibbutz Haogen, Israel), Gore-Tex™,M y c r o m e s h ™ (WL
Gore, Flagstaff, AZ, USA), Teflon™ (Davol/Bard, Cranston,
RI, USA). Prolift™ was the most removed mesh material in
our patients (40%). The mesh insertion surgery was performed
at our center in 41% of patients; in 59%, mesh was inserted at
other hospitals.
Frequency of signs and symptoms and the distribution
between different types of mesh insertion procedure are
presented in Table 2. Fifty-seven (76%) patients had mesh
exposure, of which most were localized in the vaginal wall
(90%). Furthermore, four patients had an exposure in the
bladder (three after TVT™, one after Prolift™), two
patients had a vesicovaginal fistula (after Prolift™), and
one patient had a rectovaginal fistula (after sacrocolpo-
pexy). Most women reported more than one mesh-related
symptom. Only one patient did not report any symptoms,
although she had a persistent, large exposure of the mesh.
The primary complaint was pain in the majority of cases
(77%), which consisted of dyspareunia, vaginal pain,
chronic pain of the abdomen, back, buttock, or leg, or a
combination of these. A distinct difference in frequency of
mesh-related symptoms existed between the different types
of mesh insertion procedure, especially in sacrocolpopexy
compared to the other procedures (Table 2). Pain and
dyspareunia are mainly seen after vaginal mesh insertion
and vaginal bleeding and discharge after sacrocolpopexy.
Patients with mesh exposure also presented differently than
patients without exposure. They reported less pain symp-
toms (54% vs 94%, P=0.002) and more often vaginal
bleeding and discharge (32% vs 6%, P=0.031 and 47% vs
6%, P=0.002).
Patients with severe mesh complications, patients with
exposure in the bladder or fistula, and patients that have
had a previous mesh excision underwent more often
Table 1 Patient demographics and preoperative characteristics
All, N=75
(100%)
Partial excision, n=48
(64%)
Complete excision, n=27
(36%)
P value
Age (years) 56±11 54±10 59±10 0.034
BMI
a 26±4 26±4 26±3 0.822
Smoking
b 12 (16) 11 (23) 1 (4) 0.046
Comorbidity 49 (65) 33 (69) 16 (59) 0.407
History of POP/SUI surgery prior to mesh insertion 56 (75) 35 (73) 21 (78) 0.642
No. of previous POP/SUI surgeries 2 (0–7) 2 (0–7) 2 (0–4) 0.835
Previous hysterectomy 58 (77) 35 (73) 23 (85) 0.223
Procedure mesh insertion
Anterior repair 14 (19) 7 (15) 7 (26) 0.226
Posterior repair 15 (20) 13 (27) 2 (7) 0.041
Total mesh/anterior–posterior repair 19 (25) 14 (29) 5 (19) 0.309
Sacrocolpopexy 12 (16) 5 (10) 7 (26) 0.104
Retro pubic incontinence sling 6 (8) 3 (6) 3 (11) 0.661
Transobturator incontinence sling 9 (12) 6 (13) 3 (11) 1.000
POP-Q stage before mesh excision
c
POP-Q stage 0 31 (43) 18 (39) 13 (50) 0.371
POP-Q stage I 11 (15) 10 (22) 1 (4) 0.048
POP-Q stage II 25 (35) 16 (35) 9 (35) 0.989
POP-Q stage III 5 (7) 2 (4) 3 (12) 0.344
Former mesh excision 22 (29) 6 (13) 16 (59) <0.001
No. of former mesh excisions 0 (0–4) 0 (0–1) 1 (0–4) <0.001
Values are presented as mean±SD, median (range), or number (%). P value represents a comparison between the groups “partial excision” and
“complete excision”
aMissing, n=4; partial excision, n=1; complete excision, n=3
bMissing, n=1; partial excision, n=1
cMissing, n=3; partial excision, n=2; complete excision, n=1
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have these severe complications (73% vs 27%, P=0.001,
83% vs 29%, P=0.017, and 73% vs 21%, P<0.001,
respectively).
Mesh-related complications were unsuccessfully treated
conservatively with estrogen cream, antibiotics, and/or
physiotherapy prior to mesh excision in 63% of patients.
Previous mesh excision procedures were performed in 22
patients (29%). Five patients had two or more previous
excisions. Three patients had undergone an earlier attemp-
ted complete excision.
Characteristics of mesh excision surgery are presented in
Table 3. Complete mesh excisions were frequently assisted
by a urologist, especially in complex cases and with bladder
involvement. Mesh was most often (89%) excised by a
vaginal approach. In five cases, abdominal approach was
combined with vaginal excision, and in one case, it was a
laparoscopic approach. Additional POP repair surgery was
performed in 14 patients (17%). These were, except for one
patient, classical repairs without mesh and in 10 out of 14 of
another compartment then where the mesh was removed.
Additional surgery led to a longer operation time (mean, 66±
24 vs 35±31 min; P<0.001).
Intraoperative complications occurred during four surgi-
cal procedures: three patients had a bowel lesion (one
perforation of the sigmoid and two serosal lesions of the
colon and small bowel), which occurred during abdominal
mesh excision for previous sacrocolpopexy and were
repaired during surgery. Postoperatively, one patient devel-
oped anuria as a consequence of lesions to both ureters,
which had remained unnoticed during surgery. During this
procedure of complete vaginal excision of mesh located at
the anterior vaginal wall, dissection of the mesh from the
bladder wall was difficult. However, at that moment, there
was no suspicion of damage to the ureters. A bladder lesion
was excluded by filling the bladder with methylene blue
dye. Once this serious complication was identified, she was
treated successfully with bilateral ureter reimplantation.
Table 2 Presenting mesh-related symptoms and signs per type of mesh insertion procedure
All, N=75
(100%)
Sacrocolpopexy,
n=12 (16%)
Vaginal POP repair,
n=48 (64%)
Suburethral slings,
n=15 (20%)
P value
Exposure 57 (76) 11 (92) 34 (71) 12 (80) 0.294
Vagina 51 (90) 10 (91) 31 (91) 10 (83) 0.737
Bladder 3 (5) 0 (0) 1 (3) 2 (17) 0.128
Vesicovaginal fistula 2 (4) 0 (0) 2 (6) 0 (0) 0.496
Rectovaginal fistula 1 (2) 1 (9) 0 (0) 0 (0) 0.119
Symptoms
Vaginal bleeding 19 (25) 9 (75) 8 (17) 2 (13) <0.001
Vaginal discharge 28 (37) 10 (83) 16 (33) 2 (13) 0.001
Dyspareunia 42 (56) 2 (17) 31 (65) 9 (60) 0.011
Pain (vaginal pain and/or chronic pain) 48 (64) 3 (25) 34 (71) 11 (73) 0.009
Vaginal pain 43 (57) 2 (17) 32 (67) 9 (60) 0.007
Chronic pain 32 (43) 2 (17) 23 (48) 7 (47) 0.138
Abdomen 17 (53) 1 (50) 12 (52) 4 (57) 0.970
Back 3 (9) 0 (0) 3 (13) 0 (0) 0.523
Buttock 8 (25) 1 (50) 7 (30) 0 (0) 0.186
Leg 4 (13) 0 (0) 1 (4) 3 (43) 0.023
Urinary tract infections 4 (5) 3 (25) 0 (0) 1(7) 0.003
Defecation problems 8 (11) 2 (17) 6 (13) 0 (0) 0.299
Dysfunctional voiding 3 (4) 1 (8) 1 (2) 1 (7) 0.516
Severe mesh complications 15 (20) 1 (8) 13 (27) 1 (7) 0.123
Mesh shrinkage 8 (11) 0 (0) 8 (17) 0 (0) 0.081
Mesh displacement 1 (1) 0 (0) 1 (2) 0 (0) 0.752
Chronic inflammation 2 (3) 0 (0) 2 (4) 0 (0) 0.561
Infection 1 (1) 0 (0) 1 (2) 0 (0) 0.752
Granuloma 7 (9) 1 (8) 5 (10) 1 (7) 0.902
Values are presented as number (%). P value represents a comparison between the groups “sacrocolpopexy,”“ vaginal POP repair,” and
“suburethral slings”
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procedures, including hematoma (n=2), substantial bleed-
ing (n=1), ileus (n=1), urinary tract infection (n=5),
urinary retention (n=3), fever (n=2), wound infection (n=
1), subcutaneous abscess (n=1), fistula from cervix to
sigmoid (n=1), obstruction of a unilateral ureter and
consequently blow-out of the kidney (n=1). The latter
serious complication occurred in a patient who appeared to
have a bilateral relative ureteropelvic junction stenosis,
which probably was aggravated by the surgery. She was
treated by temporary insertion of a nephrostomy catheter.
Complications seemed to be more frequent in the group
with complete mesh excision, although this difference was
not statistically significant.
Complications were more common in the group with
former sacrocolpopexy; intraoperative complications in this
group occurred in 23% (vs 1%, P=0.001) and, only during
abdominal excision, postoperative complications in this
group occurred in 46% (vs 12%, P=0.003). All patients
recovered completely after treatment of their complications.
Outcomes are shown in Table 4. The majority of patients
had relief, either complete relief or improvement, of mesh-
related symptoms (92%). No difference was found between
groups with regard to symptom relief, although five of six
patients with no relief of symptoms had undergone a partial
excision. Nine patients (12%) had recurrence of POP, of
which eight were in the anterior compartment. The
recurrence rate of POP was significantly higher in patients
who underwent complete excision of mesh used in POP
surgery (29%) compared to patients who underwent partial
excision (5%). De novo SUI after mesh excision was more
frequent in the group of patients who underwent excision of
suburethral slings (36%) compared to patients who under-
went excision of mesh used in POP surgery (7%, P=0.010).
Six patients (8%) needed re-excision of mesh; all had
undergone a partial excision before. Four had persistent
exposure of mesh in the vagina, one had a new exposure of
mesh in the bladder, while she earlier had an exposure of
mesh in the vagina, and one had persistent pain. Three
patients underwent additional complete excision and three
Table 3 Characteristics of mesh excision surgery
All, N=81
(100%)
Partial excision,
n=51 (63%)
Complete excision,
n=30 (37%)
P value
Time between mesh insertion and recent excision (months) 16 (2–217) 11 (2–208) 26 (5–217) 0.001
Assistance of urologist 10 (12) 1 (2) 9 (30) <0.001
Operation time (min) 43±29 34±26 58±28 <0.001
Blood loss (ml) 77±147 52±107 120±193 0.066
Site of mesh excision
Anterior vaginal wall 22 (27) 14 (27) 8 (27) 0.939
Posterior vaginal wall 18 (22) 14 (27) 4 (13) 0.140
Anterior and posterior vaginal wall 5 (6) 5 (10) 0 (0) 0.152
Anterior and posterior vaginal wall and vaginal vault 2 (2) 0 (0) 2 (7) 0.134
Vaginal vault 22 (27) 10 (20) 12 (40) 0.046
Suburethral 19 (23) 11 (21) 8 (27) 0.601
Approach
Vaginal
a 72 (89) 49 (96) 23 (77) 0.011
Abdominal
b 9 (11) 2 (4) 7 (23) 0.011
Use of hysteroscope 2 (2) 0 (0) 2 (7) 0.134
Use of laparoscope 1 (1) 1 (2) 0 (0) 1.000
Additional surgery 21 (26) 13 (25) 8 (27) 0.907
POP 14 (17) 8 (16) 6 (20) 0.762
SUI 3 (4) 2 (4) 1 (3) 1.000
Other 4 (5) 3 (6) 1 (3) 0.609
Intraoperative complications 4 (5) 1 (2) 3 (10) 0.141
Postoperative complications 13 (16) 5 (10) 8 (27) 0.062
Hospital stay (days) 2±2 1±1 3±2 <0.001
Values are presented as mean±SD, median (range), or number (%). P value represents a comparison between the groups “partial excision” and
“complete excision”
aTwo combined with hysteroscopy
bFive combined with vaginal excision, one with laparoscope
1400 Int Urogynecol J (2011) 22:1395–1404had partial excision. Eventually, after this re-excision, five
patients had complete relief and one had improvement of
symptoms, none had exposure, none had recurrence of POP,
one had de novo SUI, and one had de novo OAB.
The group of patients who underwent excision of mesh
used in sacrocolpopexy was not different from the other
groups concerning the outcomes. All had relief of symp-
toms (23% improvement and 77% complete relief of
symptoms), none had exposure, three (25%) had recurrence
of POP, one had SUI and one had OAB after mesh excision,
and one patient needed re-excision of mesh.
Discussion
In this retrospective cohort study, we demonstrated that
surgical mesh excision to treat complications after prior
POP or SUI surgery with mesh was successful in the
majority of cases, although with a substantial risk of serious
complications and recurrence of POP or SUI. Only 8% of
patients experienced no improvement of their symptoms.
Main indications for mesh removal included pain (dyspar-
eunia, vaginal pain, and/or pain in the lower abdomen,
back, buttock, or leg), vaginal bleeding, and discharge, with
or without evident mesh exposure. The frequency of these
symptoms differed substantially between different types of
mesh insertion procedure, but was similar to numbers found
in other studies [14–17, 23, 24]. Pain and dyspareunia are
mainly seen after vaginal mesh insertion and vaginal
discharge and bleeding after sacrocolpopexy.
Mesh exposures are often reported as painless [8, 9, 16];
however, pain is still found frequently together with
exposures [14, 15, 17]. In our study, pain and mesh
exposure were both frequently reported; however, patients
with mesh exposure reported less pain symptoms than
patients without exposure. Still, 54% of patients with mesh
exposure did report pain symptoms (excluding dyspareunia,
which is often already present before mesh insertion [8,
20]). The exposure itself may not have been the cause of
pain. Underlying mesh contraction, although less severe
contraction may not always be recognized at physical
examination, could actually have induced the pain symp-
toms [25]. It may also be possible that more complex cases
of mesh exposures were seen at our tertiary referral center,
in which pain may be more frequently present than in
patients with less severe exposures.
Most of the recent publications on vaginal mesh surgery
report only short-term and medium-term follow-up results.
Indeed, most of the mesh complications occur within the
first postoperative year [9]. However, late complications
Table 4 Outcomes of mesh excision
All, N=75 (100%) Partial excision, n=48 (64%) Complete excision, n=27 (36%) P value
Relief of mesh-related symptoms 69 (92) 43 (90) 26 (96) 0.410
No improvement 6 (8) 5 (10) 1 (4) 0.410
Improvement 21 (28) 14 (29) 7 (26) 0.764
Complete relief 48 (64) 29 (60) 19 (70) 0.389
Persistent exposure after mesh excision 6 (8) 6 (13) 0 (0) 0.082
POP-Q stage after mesh excision
a
POP-Q stage 0 24 (35) 14 (32) 10 (42) 0.417
POP-Q stage I 18 (27) 15 (34) 3 (13) 0.054
POP-Q stage II 19 (28) 14 (32) 5 (21) 0.335
POP-Q stage III 7 (10) 1 (2) 6 (25) 0.006
Recurrence of POP
b 9 (12) 3 (6) 6 (23) 0.061
Recurrence of POP (POP mesh only, n=60)
c 8 (14) 2 (5) 6 (29) 0.019
De novo SUI after mesh excision
d 9 (12) 5 (11) 4 (15) 0.712
De novo OAB after mesh excision
e 6 (8) 2 (4) 4 (15) 0.178
Follow-up (months) 6 (0–50) 5 (0–50) 7 (1–42) 0.557
Need of re-excision 6 (8) 6 (13) 0 (0) 0.082
Values are presented as median (range) or number (%). P value represents a comparison between the groups “partial excision” and “complete
excision”
aMissing, n=7; partial excision, n=4; complete excision, n=3
bMissing, n=2; partial excision, n=1; complete excision, n=1
cMissing, n=1; partial excision, n=1
dMissing, n=2; partial excision, n=1; complete excision, n=1
eMissing, n=2; partial excision, n=1; complete excision, n=1
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related complications even up to 18 years after mesh
insertion and, in 36% of mesh excisions, the time between
mesh insertion and removal was more than 2 years, mostly
after sacrocolpopexy. Marcus-Braun et al. found mesh-
related complications up to 8 years after mesh placement; in
56%, the delay from the primary operation was more than
2 years [13]. Time between mesh insertion and excision
was longer in the group of patients who underwent
complete mesh excision, probably because they have
undergone more minor interventions (former partial mesh
excision) to treat their complications in this period.
Not every mesh-related complication requires complete
excision, although complete excision of mesh is sometimes
advocated to avoid multiple procedures and to achieve
optimal relief of symptoms [14, 24, 26]. In our study, most
patients (64%) underwent partial excision of mesh. Never-
theless, we found no difference in relief of symptoms
between partial and complete excision. Ridgeway et al.
described 19 cases of mesh removal in which the degree of
mesh excision was tailored to the severity of the compli-
cations. This resulted also in great alleviation of symptoms
in most cases [16]. In our series, patients with more serious
complaints indeed underwent more often a complete mesh
excision.
A substantial number of patients (36%) required multiple
procedures, of which most had been performed in other
centers before referral to our hospital. This corresponds
with numbers of women requiring multiple procedures
found by others ranging from 20% to 38% [13, 15, 26].
This number may be overestimated in a tertiary referral
center, as the more straightforward cases of mesh exposure
that are recovered with a single (office) excision will not be
referred.
Recurrence of POP after excision of mesh used in POP
surgery was more common with complete excision than
with partial excision (29% vs 5%) and affected the anterior
vaginal wall in 7 of 47 (15%) cases of mesh excision from
the anterior vaginal wall or vaginal vault. Nevertheless,
consistent with a previous study, the majority of patients
(86%) did not have recurrence of POP after mesh excision
[13]. Possibly, the formation of scar tissue and fibrosis after
mesh insertion surgery provides sufficient support to
prevent the recurrence of POP in most patients who had
mesh excision, even though in complete mesh excision the
interlaced fibrotic tissue may be removed. De novo SUI
after mesh excision occurred in 13% of all patients and
reoccurred in 36% after excision of a suburethral sling,
which is consistent with recurrence rates of SUI up to 47%
after suburethral sling excisions in other studies [13, 27].
The small amount of scar tissue around the suburethral tape
is often not enough to remain supportive after mesh
excision.
In two of our patients (who underwent surgery without the
assistance of a urologist), very serious urologic complications
occurred. Bilateral ureter lesion occurred in one of the first
complete excisions of vaginal mesh performed at our center.
Thisincidenthasledtoapolicyinwhichtheurologistisbeing
involved with the more extensive and complex surgeries.
Also, the urologist is always involved in the treatment of
patients with (suspected) mesh complications affecting the
bladder.
Furthermore, intraoperative and postoperative complica-
tions (5% and 16%, respectively) were found relatively
frequent in our study compared to the study of Marcus-
Braun et al. [13]. In their retrospective study of 104 cases of
surgical vaginal mesh removal, intraoperative complications
occurred only twice (2%) and postoperative complications in
10 operations (10%). However, they did not evaluate patients
with mesh excision after sacrocolpopexy. Most complica-
tions in our patients occurred in the group of patients who
underwent abdominal excision of mesh used in sacrocolpo-
pexy. This is consistent with the findings of South et al. who
described that abdominal excision of eroded vaginal mesh
after prior abdominal sacrocolpopexy involves more serious
complications compared to the vaginal route [26].
The impact of this study is limited by its retrospective
design and descriptive nature. It is, therefore, susceptible to
recall and interpretation bias. Moreover, since data were
collected retrospectively, 32% of the patients had a follow-
up of only 2 months. Therefore, the postoperative follow-up
may have been too short to find recurrences of POP in
some cases. Furthermore, 17% of patients underwent
concomitant POP or SUI surgery, which may have reduced
the rate of recurrence of POP and de novo SUI we found.
Incidence figures are hard to reproduce in this heteroge-
neous population, in which patients were often referred by
various other hospitals. We were able to estimate the
incidence of mesh-related complications only for Prolift™
inserted at our center. Of the patients included in this study,
20 underwent insertion of Prolift™ at our hospital between
halfway of 2005 and end of 2009. In this period, 180
Prolift™ meshes were inserted. So, 20 out of 180 (11%)
patients with Prolift™ inserted at our center developed
complications that required excision. All 20 patients
initially underwent partial excision, of which 2 required a
re-excision (1 partial and 1 complete). As these patients
originated from our center, the excisions included both
minor and major complications. It can be concluded that,
after the insertion of Prolift™, 0.6% needs excision for
severe mesh-related complications and 11% for minor
complications. This incidence number is consistent with
numbers found in other studies [9, 13, 21].
Prolift™ was the most removed mesh material in our
patients (40%). This could be explained by the fact that, in
this region, Prolift™ is the most used mesh material in
1402 Int Urogynecol J (2011) 22:1395–1404prolapse repairs. Since it is impossible to generate a
denominator for each mesh type and patients referred from
other centers, no inference can be made on the overall
incidence of mesh complications in the population or the
relative complication rates related to individual mesh kits.
Different types of mesh may be more likely to erode and
others may be easier to excise.
Despite these limitations, this study is strengthened by
the relatively large number of patients, the fact that all
operations were performed in one center using the same
surgical techniques, and the detailed data available from
operative reports and medical records. Moreover, this study
shows that mesh complications after abdominal sacrocol-
popexy and transvaginal mesh present differently and that
patients who undergo complete mesh excision have a
higher recurrence rate of POP compared to those who
required only partial mesh excision, observations that are
relatively new to the literature.
Conclusion
There is a great variety of mesh-related complications,
which present differently after abdominal sacrocolpopexy
and transvaginal mesh insertion. Excision of mesh to treat
these complications is challenging. It often requires
extensive dissection and careful operative technique. Relief
of symptoms is achieved in the majority of patients.
Although complications do not occur frequently, serious
complications may be associated with more extensive or
complex surgery. Therefore, we recommend centralization
of complete mesh excision, especially when there is
involvement of the bladder or rectum. In these cases, the
role of the urologist or colorectal surgeon is important to
avoid serious organ-specific complications. Checking the
ureters after all cases involving any anterior vaginal wall or
bladder dissection by cystoscopy to avoid reoperation for
ureteric complications should be considered. Partial excision
should be preferred in more straightforward cases of mesh
exposure with relatively mild symptoms. Complete excision
should be reserved for patients with more serious complaints
and severe mesh-related complications because of the higher
risk of surgical complications and recurrence of POP. The
vaginal mesh excision procedure with or without hysteroscopy
would be the preferred method to approach patients with
symptoms of sacrocolpopexy mesh because it is less invasive
and associated with less morbidity than the abdominal
approach. Concomitant repair of POP or incontinence surgery
should be considered given the rates of recurrence of POP and
de novo SUI, especially after complete mesh excision.
The increasing number of inserted meshes for SUI and
POP raises concerns. Mesh is successfully used for repair
of prolapse, but when complications arise, they may be
severe in nature and result in a decrease in quality of life.
New meshes are introduced into clinical practice despite the
lack of proper studies showing their safety and effective-
ness. Moreover, the use of easy-to-do mesh kits lowers the
threshold for inexperienced surgeons to start operating with
meshes. This can only lead to more complications, which is
harmful for the patients. The Food and Drug Administra-
tion also has noticed this and has given a firm warning
about the use of mesh and how to consult patients [28].
This strengthens us in our opinion that insertion of mesh
and the use of kits should be done with utmost skill and
only by trained and very experienced surgeons.
The precise impact of mesh-related complications on
quality of life has not been researched yet. Therefore, we
encourage a future study evaluating the impact of mesh-
related complications on the quality of life of patients.
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